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Nonintegrating lentiviral vectors present a means of 
reducing the risk of insertional mutagenesis in nondivid-
ing cells and enabling short-term expression of potentially 
hazardous gene products. However, residual, integrase-
independent integration raises a concern that may limit 
the usefulness of this system. Here we present a novel 
3′ polypurine tract (PPT)-deleted lentiviral vector that 
demonstrates impaired integration efficiency and, when 
packaged into integrase-deficient particles, significantly 
reduced illegitimate integration. Cells transduced with 
PPT-deleted vectors exhibited predominantly 1–long 
terminal repeat (LTR) circles and a low level of linear 
genomes after reverse transcription (RT). Importantly, 
the PPT-deleted vector exhibited titers and in vitro and 
in vivo expression levels matching those of conventional 
nonintegrating lentiviral vectors. This safer nonintegrat-
ing lentiviral vector system will support emerging tech-
nologies, such as those based on transient expression of 
zinc–finger nucleases (ZFNs) for gene editing, as well as 
reprogramming factors for inducing pluripotency.
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IntroductIon
The notion that there is an inherent risk of insertional mutagen-
esis in all integrating vectors1,2 gives impetus for the development 
and use of nonintegrating lentiviral vectors in vitro and in vivo. 
The nonintegrating lentiviral vectors most commonly used in 
 current studies are generated by packaging vectors with a mutated 
integrase gene bearing one of several nonpleiotropic mutations 
at the integrase’s catalytic-core domain that specifically disrupt 
integration.3
To date, nonintegrating lentiviral vectors have been used to 
deliver transgenes to a number of target organs, including the eye, 
liver, brain, muscle, and lymph nodes.4–8 Importantly, the transient 
transgene expression of nonintegrating lentiviral vectors in rapidly 
dividing cells would be highly advantageous in preclinical settings 
where short-term expression of potentially genotoxic transgenes 
is required, such as the delivery of zinc–finger nucleases (ZFNs) to 
dividing cells to mediate site-specific, double-strand DNA break-
induced recombination.9 Notwithstanding these advances, the 
phenomenon of integrase-independent (illegitimate) integration 
poses a safety concern to nonintegrating lentiviral vectors that 
may restrict their utilization.10,11 Indeed, a recent study reported 
that the frequency of illegitimate integration ranged between 
0.35% and 2.3%.9
Structures of retroviral DNA found in the nucleus include 
linear episomes, formed directly by reverse transcription (RT);12 
2-long terminal repeat (LTR) circular episomes, generated by cellu-
lar nonhomologous end-joining DNA double-strand break repair 
machinery;13 and heterogeneous circular episomes, formed, at 
least in part, by self-integration.14 Interestingly, 1-LTR circular epi-
somes are formed either by the host cell’s homologous recombina-
tion (HR) double-strand break repair pathway15 or as abortive RT 
products.16,17 The specific episomal form contributing to illegitimate 
integration has not been established, although studies conducted 
on plasmid DNA suggest that linear DNA integrates much more 
efficiently than supercoiled circular DNA.18 To extend and refine 
these observations, we hypothesized that minimizing the formation 
of linear episomes may be a strategy for reducing the magnitude of 
illegitimate integration. In this regard, we perceived the possibility 
of enhanced 1-LTR circle formation prior to the completion of RT 
as a means of altering the natural formation of linear episomes, and, 
consequently, reducing illegitimate integration. This approach was 
premised on the notion that 1-LTR circles are formed, in part, as 
natural by-products of incomplete RT, which occurs in the absence 
of strand displacement.12,19 We hypothesized that this phenomenon 
could be enhanced by deleting the vector’s 3′ polypurine tract (PPT), 
thus forcing initiation of plus-strand synthesis from non-PPT 
sequences.19,20 Indeed, we describe here novel PPT-deleted HIV-1 
vectors, which produce predominantly 1-LTR circular genomes 
and reduced levels of linear genomes. Consequently, integrase-
mediated integration and 2-LTR circle formation, which require 
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linear genomes as substrates,13 were reduced tenfold and three-
fold, respectively. Interestingly, analysis of 2-LTR circles formed by 
PPT-deleted vectors revealed unique cryptic plus-strand initiation 
sites. Furthermore, PPT-deleted  vectors packaged into integrase-
 deficient particles exhibited in vitro and in vivo titers and expression 
levels comparable to the levels of conventional nonintegrating vec-
tors. Importantly, the level of illegitimate (integrase-independent) 
integration from PPT-deleted vectors was approximately threefold 
lower than the levels of illegitimate integration from conventional 
integrase- deficient vectors.
results
efficient formation of 1-ltr circles under  
conditions that do not favor Hr
We hypothesized that aberrant RT, which does not complete the 
final strand-displacement step, may account for the formation of 
some 1-LTR circles, and that inhibiting HR would, therefore, only 
partially reduce the formation of 1-LTR circles in vector- transduced 
cells. To this end, we transduced either cell lines mutant for the HR 
factors BRCA121 or Ercc1.22 Also, to address the possibility that HR 
enzymes other than BRCA1 and Ercc1 are responsible for 1-LTR 
circle formation, we transduced cultured cells arrested in G1 phase 
of the cell-cycle, in which HR is not active.23,24 Furthermore, to 
analyze episome formation in a physiologically relevant, nondivid-
ing cell type, we examined 1-LTR circle formation in liver tissue 
(a major target organ for gene therapy), which is primarily in G1/
G0 phase and, thus, is not expected to exhibit a high level of HR 
activity. Relative abundance of episomal forms was determined 
by Southern-blot analysis of total DNA from transduced cells or 
through a shuttle–vector assay. As described earlier,5,25 shuttle vec-
tors contain a drug resistance gene and bacterial origin of replication 
upstream of the vectors’ 3′ LTR, which allows the Hirt extraction 
of circular vector genomes from transduced cells, individual-
clone amplification in bacteria, and restriction-digest analysis of 
the vectors’ circular episomes (Figure 1, Supplementary Figure 
S1). The data presented in Figure 1 demonstrated that transduced 
HR factor-deficient cell lines, mutated for either BRCA1 or Ercc1, 
did not exhibit a reduction in 1-LTR circles relative to linear epi-
somes (Figure 1a,d). Similarly, transduced G1-arrested cells also 
did not show a decrease in the 1-LTR circular forms (Figure 1c,d, 
Supplementary Figure S2 confirms G1 arrest). Consistent with 
these results, analysis of episome formation in the liver (Figure 1b) 
was in the range of normal  episome formation, as observed in a 
previous study.5 These data suggest that incomplete RT could be 
the primary source of 1-LTR circles in transduced cells (Figure 2).
PPt deletion decreases the levels of linear vector 
forms and enhances the formation of 1-ltr circles
We hypothesized that initiating plus-strand synthesis at non-
PPT (cryptic) sites may inhibit strand displacement, thereby 
altering the RT process and leading to an increase in the levels 
of 1-LTR circles. Accordingly, we deleted the 3′ PPT, which bor-
ders the 3′LTR and serves as a primer for plus-strand synthesis, 
and characterized the effect of the deletion on episome forma-
tion. However, the modified vectors retained the central PPT 
(cPPT) (Supplementary Figure S1). We used either PPT-positive 
(vTK945) or PPT-deleted (vTK1179) lentiviral vectors (outlined 
in Supplementary Figures S1 and S3), packaged with or without 
functional integrase, to transduce human embryonic kidney 293T 
cells. To characterize episome formation, we employed Southern-
blot analysis with probes complementary to either the vectors’ 5′ 
or 3′ regions (Figure 3). Importantly, as observed when using the 
probe complementary to the vectors’ 5′ regions (Figure 3a,c), the 











































































Figure 1 Analysis of lentiviral vector episome formation under conditions not conducive to homologous recombination. Shuttle vector analysis 
(see Materials and Methods) was employed on Hirt-extracted episomes from lentiviral shuttle vector-transduced (a) Ercc1-defective Chinese hamster 
ovary (E1KO7-5) cells, (b) liver cells, and (c) cycle-arrested Chinese hamster ovary (AA8 cells). Panels a–c represent episome formation as a percent-
age of total episomes; each experiment was performed in triplicate. The term “mutant” refers to circular vector genomes generated by autointegra-
tion, as determined by restriction products that do not fit the expected band sizes corresponding to 2-long terminal repeat (LTR) and 1-LTR circular 
episomes. (d) Episome formation was examined by Southern-blot analysis on DNA extracted 2 days after transduction with an integrating, polypurine 
tract+ vector (vTK945) from Ercc1-deficient (E1K07-5) (lane 1), Ercc1-wild-type (ATStg) (lane 2), cycling AA8 (lane 3), arrested AA8 (lane 4), human 
breast cancer BRCA1-deficient (SUM149) cells (lane 5), and human breast cancer (ME16C2) cells containing wild-type BRCA1 (lane 6). DNA was 
digested with EcoNI and PflMI and probed with the probe complementary to the 3′ region of vTK945, as shown in Figure 3b.
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and eliminated linear episome formation. Interestingly, employ-
ing a probe complementary to the 3′ end of the vectors’ genomes 
(Figure 3b) showed that PPT-deleted vectors produce detectable 
levels of linear episomes, though at roughly a threefold lower level 
than PPT-positive vectors (Figure 3d) (Supplementary Table S1). 
These data support our notion that the aberrant RT induced by 
the PPT deletion mediates plus-strand synthesis from several cryp-
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Figure 2 Proposed model for episome formation and integration in cells transduced with polypurine tract (PPt)-positive or PPt-deleted 
 vectors. (a) The RNA genomes of PPT-positive vectors undergo plus-strand synthesis (depicted as a dashed line) initiation at the PPT, leading to 
efficient strand displacement and producing primarily linear episomes, with a small number of 1-long terminal repeat (LTR) circles formed by failed 
strand displacement. Linear episomes may then serve as the substrates for homologous recombination (HR), forming 1-LTR circles; nonhomologous 
end-joining (NHEJ), forming 2-LTR circles; and integrase-mediated integration, forming integrated provirus. (b) The RNA genomes of PPT-deleted 
(ΔPPT) vectors undergo plus-strand synthesis initiation at cryptic sites upstream or downstream of the PPT, leading to inefficient strand displacement 
and producing primarily 1-LTR circles (plus-strand synthesis is represented by dashed lines). However, in the few instances in which initiation of plus-
strand synthesis from non-PPT sites (from sites located either upstream to the deleted PPT or in the 3′U3) is followed by strand displacement, the 
aberrant episomal linear forms contained either additions to their 5′ ends or deletions in the 5′ U3 region. NHEJ-mediated circularization of these 
aberrant linear forms generate 2-LTR circles containing either an insertion between the LTRs or a deletion in the 5′ U3 region. The aberrant linear 
forms that lack the 5′ integrase attachment (att) site do not support efficient integrase-mediated integration.
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uniform (detectable) 3′ end, but with a heterogeneous 5′ end, which 
could not be detected by the 5′ probe (Supplementary Figure S4). 
Interestingly, this data was supported by a Southern-blot analysis 
of undigested genomic DNA extracted from cells transduced with 
PPT+ (vTK945) and PPT-deleted (vTK1179) vectors, which exhib-
ited predominantly linear and 1-LTR episomal forms, respectively 
(Supplementary Figure S5). Furthermore, concomitant with the 
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Figure 3 Analyzing the effect of the polypurine tract (PPt) deletion on lentiviral vector episome formation. (a,b) Outline of Southern-blot 
analysis used to characterize vector provirus and episomes by probing at the (a) 5′ and (b) 3′ regions of the genome. After extracting vector DNA 
from transduced cells, digestion with EcoNI and PflMI, and probing with either (a) a KasI/BamHI fragment of at PPT+ vector (vTK945) or (b) a AfeI/
EcoRV fragment of vTK945, bands indicative of total episomes and integrated provirus (2.7 kb), 2-long terminal repeat (LTR) circles (1.6 kb), 1-LTR 
circles (1.3 kb), and linear episomes (0.8 kb) were determined. (c) Cells were transduced with a PPT+ vector (vTK945), integrating (lanes 1 and 5) 
or nonintegrating (lanes 3 and 7), or with a PPT− vector (vTK1179), integrating (lanes 2 and 6) or nonintegrating (lanes 4 and 8) and total DNA 
was extracted from transduced cells 3 days (no passages) (lanes 1–4) or ~14 days (four passages (p4)) (lanes 5–8) post-transduction, digested as 
shown in a and b, and analyzed by Southern blot, using the EcoNI-spanning probe complementary to the 5′ region of the virus. (d) Cells were 
transduced with the PPT+ vector, integrating (lanes 1 and 5) or nonintegrating (lanes 2 and 6), or with the PPT− vector, integrating (lanes 3 and 7) 
or nonintegrating (lanes 4 and 8) and total DNA was extracted from transduced cells 3 days (no passages) (lanes 1–4) or ~14 days (p4) (lanes 5–8) 
post-transduction, digested as in (a,b), and analyzed by Southern blot, using the PflMI-spanning probe complementary to the 3′ region of the virus. 
For c,d, bands corresponding to total vector genomes, 2-LTR circular, 1-LTR circular, and linear episomal genomes, as outlined in a,b, respectively, 
are shown. (e) Sixteen hours after transduction with a non-self-inactivating (non-SIN), PPT-deleted shuttle vector (vTK1074) and its PPT-positive 
equivalent (vTK459), which were packaged with both functional integrase (IN+) and mutant integrase (IN−), episomes were harvested from 293T 
cells and analyzed by shuttle–vector assay; each transduction was performed in triplicate. (f) Episomes were harvested from 293T cells 16 hours after 
transduction with a SIN, PPT-deleted shuttle vector (vTK1046) and its PPT-positive equivalent (vTK1054), which were packaged with IN+ and IN−, 
and analyzed by shuttle–vector assay; each transduction was performed in triplicate. For e,f, the data are presented as percentages of 1-LTR, 2-LTR, 
and mutant forms out of the number of total episomes.
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corresponding reduction of 2-LTR circle formation (Figure 3c–f), 
consistent with the previously established model that 2-LTR circles 
are formed from linear episomes by the process of nonhomologous 
end joining.13 The effect of the PPT deletion on episome formation 
was further confirmed by employing novel PPT-deleted shuttle 
vectors. In keeping with the result of the Southern-blot analysis, 
we found that the relative proportion of 1-LTR circles produced 
by non-self-inactivating PPT-deleted vectors increased from 
79.5% to 93.3% (IN+) and from 66.2% to 95.3% (IN−) (Figure 3e). 
Furthermore, the relative abundance of 2-LTR circles was concom-
itantly reduced by the PPT deletion, to 1.77% (integrase-proficient 
(IN+)) and 1.87% (integrase-mutant (IN−)), compared with 12.6% 
and 30.7%, respectively, in PPT-positive vectors (Figure 3e), which 
was in keeping with the reduction in linear vector genomes, pos-
sibly due to inefficient strand displacement caused by cryptic plus-
strand initiation in PPT-deleted vectors, as observed in Figure 3d 
and outlined in Figure 2. Not surprisingly, the relative propor-
tion of 1-LTR circles produced by a SIN PPT-deleted vector was 
increased relative to its PPT-wild-type counterpart, while the rela-
tive proportion of 2-LTR circles generated by the PPT-deleted SIN 
vector was found to be strongly reduced (Figure 3f). Intrigued by 
the formation of linear and 2-LTR genomes produced by aberrant 
plus-strand synthesis during RT, we characterized the structure 
of the 2-LTR circles’ junctions of these non-self-inactivating vec-
tors by sequence analysis. Interestingly, all of the 2-LTR circles 
sequenced from a PPT-deleted, non-self-inactivating vector exhib-
ited wild-type 3′ LTRs, and a 5′ LTR bearing a ~180 bp deletion 
at the 5′ end of the U3; this finding indicates that positive-strand 
synthesis initiation took place within the 5′ U3 (Supplementary 
Figure S6). Next, we used shuttle–vector analysis of episome for-
mation by a SIN vector to investigate the effect of deleting the 
alternative plus-strand synthesis initiation sites in the U3 on the 
mechanism of 2-LTR circle formation. Interestingly, we found 
that 2-LTR circle formation from the SIN PPT-deleted vector, as 
determined by  shuttle–vector assay, was reduced up to threefold in 
comparison with that of a non-self-inactivating PPT-deleted vector 
(Figure 3e,f). Sequence analysis of a 2-LTR circle formed by a SIN 
PPT-deleted vector (vTK1046) revealed intact SIN LTRs flanking 
an insert of 43bp derived from the 3′ end of the vector genome, 
adjacent to the 3′ LTR (Supplementary Figure S6), which indicates 
plus-strand initiation at a cryptic site 5′ of the 3′ LTR (Figure 2). 
Intrigued by this finding, we sought to characterize the effect of the 
cPPT on the episome formation of PPT-deleted vectors. Southern-
blot analysis of SIN vectors either bearing deletions of the cPPT 
and PPT, of the PPT alone, or bearing no PPT deletions indicated 
that the dual deletion of the cPPT and PPT did not alter the relative 
abundances of episomes exhibited by vectors bearing only the PPT 
deletion (Supplementary Figure S7).
PPt-deleted vectors exhibit impaired integrase-
mediated integration and reduced illegitimate, 
integrase-independent integration
We next sought to explore the possibility that the decrease in  linear 
genomes generated by PPT-deleted vectors would result in a con-
comitant reduction in illegitimate (integrase-independent) integra-
tion of vector genomes packaged into integrase-deficient particles. 
To test this hypothesis, 293T cells were transduced with either 
wild-type or PPT-deleted vectors, as shown above (Figure 3c), 
and, after four passages (p4), were analyzed by Southern blotting 
to determine the relative abundances of  episomal and integrated 
vector genomes. As shown in Figure 3c, the PPT-deleted vectors 
did not generate an integrated-provirus signal, even in the pres-
ence of functional integrase. Hence integration was either nonexis-
tent or below the threshold of detection by Southern-blot analysis 
using a radiolabeled probe complementary to a sequence in the 
vector genome’s 5′ region. To confirm and quantify these results 
with greater sensitivity, we employed fluorescence-activated cell 
sorting analysis and quantitative PCR to measure vector-derived 
green fluorescent protein (GFP) expression and vector–genome 
persistence, respectively. As shown in Figure 4a, the integrase-
proficient, PPT-deleted (PPT-/IN+) vector produced a notably 
low level of GFP expression, with a mean fluorescence intensity 
of 40, which was typical of nonintegrating lentiviral vectors previ-
ously examined by this group and others5,9 and comparable to the 
GFP expression generated by the integrase-mutant vectors, which 
produced mean fluorescence intensities of 30 (PPT+/IN−) and 39 
(PPT-IN−); conversely, the conventional, PPT-positive, integrase-
proficient vector exhibited a high level of GFP expression (mean 
fluorescence intensity of 280). The low level of GFP expression, 
which is a hallmark of nonintegrating vectors, produced by the 
PPT-deleted vectors indicates that they fail to integrate efficiently, 
even in the presence of functional integrase. The idea that PPT-
deleted vectors integrate poorly was further supported by the find-
ing that only 2.4% of cells transduced with the PPT−/IN+ vector 
(out of 63% 3 days after transduction) still expressed GFP after p4, 
while approximately a third of cells transduced with the conven-
tional PPT+/IN+ (vTK1187) vector continued to express GFP at 
p4 (Figure 4b), which is in line with previously measured levels of 
integrase-mediated integration.5,26 Similar to earlier studies dem-
onstrating minimal vector integration in the absence of integrase 
activity,5,27 0.5% of cells transduced with integrase-deficient vec-
tors, either with or without the PPT, were GFP-positive after p4 
(compared to 50% GFP-positive cells at 3 days post- transduction). 
This low level of GFP-positive cells, generated by illegitimate inte-
gration, which is near the level of background signal detected by 
fluorescence-activated cell sorting, constituted a technical limita-
tion necessitating the use of a more sensitive, qPCR-based assay 
in order to characterize illegitimate integration more accurately. 
Accordingly, qPCR analysis of integration efficiency was deter-
mined as the ratio of vector genome copies per cell measured 
p4 post-transduction to those detected after 3 days. Indeed, as 
shown in Figure 4c, employing the qPCR assay showed that the 
integration efficiency of the PPT-deleted, integrase-proficient 
vector was 2.7%, in comparison to 27% for the PPT+, integrase-
 proficient vector, indicating that the PPT deletion alone causes a 
tenfold reduction in integration efficiency. Indeed, these results 
are in line with the results of the fluorescence-activated cell sort-
ing analysis (Figure 4b), which also indicate a roughly tenfold 
difference in integration between PPT+ and PPT-deleted, inte-
grase-competent vectors. Most importantly, the qPCR assay pro-
vided direct evidence that the PPT deletion reduced illegitimate 
integration from integrase-deficient lentiviral vectors. As shown 
in Figure 4c, the PPT−/IN− vector  exhibited an integration level 
of 0.08%. In comparison, the PPT+/IN− vector’s integration level 
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was 0.2%, which was in line with previously measured frequen-
cies of integrase-independent integration.9 Furthermore, these 
results were confirmed with similar vectors expressing luciferase, 
in which the PPT deletion reduced illegitimate integration by 2.8-
fold (Supplementary Figure S8). These results are concordant 
with the Southern-blot analysis using a 3′ probe, which indicated 
that the PPT deletion reduces linear episome formation threefold, 
suggesting that the linear form is, indeed, the major substrate for 
illegitimate integration.
PPt-deleted vectors exhibit titers comparable to 
those of conventional nonintegrating HIV-1 vectors
We sought to characterize the effects of the PPT deletion on HIV-1 




















































































































































































Figure 4 Analyzing the effect of the polypurine tract (PPt) deletion on in vitro expression and integrase-mediated or integrase-independent 
integration from lentiviral vectors. (a,b) Fluorescence-activated cell sorting analysis of green fluorescent protein (GFP) expression generated by 
PPT+ (vTK1187) (left) or PPT− (vTK1188) (right), with (IN+) (upper) or without (lower) functional integrase (IN−), in 293T cells was carried out either 
(a) at 3 days (passage 0 (p0)) or (b) four passages (p4) post-transduction. The percentage of GFP-positive cells and mean fluorescence intensity (MFI) 
are shown. (c) Quantification in 293T cells of vector integration by PPT+ (vTK1187) (dark gray) or PPT− (vTK1188) (light gray), with (IN+) (left side) 
or without (IN−) (right side) functional integrase. Integration percentage was calculated for each vector as a ratio of vector copy number per cell at 
p4 and p0. Samples subjected to the qPCR assay were analyzed in triplicate, and error bars are presented as ± SD.
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vectors were packaged into either integrase-proficient or integrase-
deficient particles. Vector titers were determined by scoring GFP-
positive cells following serial dilutions on 293T cells. As shown in 
Supplementary Table S2, the PPT-deleted vectors exhibited titers 
comparable to those of PPT-positive vectors, indicating that the 
PPT deletion did not hinder the production of vector particles.
efficient expression of transgene expression  
in the rat brain
To test the efficacy of PPT-deleted vectors in vivo, we examined the 
expression of wild-type and PPT-deleted vectors, packaged with 
and without functional integrase, 2 months after striatal infusion 
into the rat brain. As in the in vitro expression assays, we found 
that expression from the PPT-deleted vectors was comparable 
to the expression produced by the PPT+/IN− vector (Figure 5). 
These findings indicate that PPT-deleted lentiviral vectors are as 
capable of forming particles and effecting target-cell transduction 
in vivo as conventional nonintegrating vectors.
dIscussIon
This study was aimed at reducing illegitimate integration, which 
can limit the applications of nonintegrating vectors, as demon-
strated in a recent study on reprogramming somatic cells into 
stem cells.28 Attempts to reduce illegitimate integration by solely 
targeting the integration pathway through mutating the vector’s 
attachment sites in combination with integrase mutations have 
not been successful.6,27 In a different approach, we sought to 
reduce the illegitimate integration of lentiviral vectors by enhanc-
ing the formation of 1-LTR circles, which are not substrates for 
integration. This strategy was premised on earlier publications 
indicating that 1-LTR circles are natural products of RT,29 gen-
erated in the absence of strand displacement.19 This scheme was 
further predicated on the notion that the PPT deletion could 
alter the RT process, directing the plus-strand initiation site 
to cryptic sites (Figure 2); indeed, previous in vitro and in vivo 
 studies with HIV-1 have indicated that, in the course of RT, HIV-1 
second-strand synthesis can be initiated from non-PPT sites.20,30–32 
Furthermore, premised on earlier studies18 suggesting that linear 
DNA is more prone to integrase-independent integration than 
circular DNA, we postulated that the decrease in the formation of 
linear genomes would correspond with a decrease in illegitimate 
integration of vector genomes. Indeed, the data presented here 
indicated a threefold reduction in linear genomes after deletion of 
the PPT, with a comparable reduction in illegitimate integration of 
HIV vectors packaged without functional integrase. Interestingly, 
the relative reduction of 2-LTR circle formation, as measured by 
the shuttle–vector assay, was more pronounced than the reduc-
tion in the linear form, as measured by Southern-blot analysis. 
Furthermore, the PPT-deleted SIN vectors showed even lower 
2-LTR circle formation. This finding may be attributed to diffi-
culties in transforming bacteria with oversized episomal genomes 
generated following plus-strand synthesis initiation at cryptic sites 
located significantly upstream of the vector’s 3′ LTR (Figure 2 and 
Supplementary Figure S4). These putative linear RT products 
may contain more than one bacterial origin of replication, which 
would not be conducive to colony formation, as required by the 
shuttle–vector assay. Overall, our results support the idea that 
reducing integration at two different steps of the viral life cycle, by 
(i) using a novel PPT deletion to decrease linear episome forma-
tion during RT, and (ii) inhibiting integrase activity using non-
pleiotropic integrase mutations, decreases illegitimate integration 
significantly. The data presented here demonstrate a more effica-
cious method of reducing illegitimate integration than utilizing 
integrase mutations alone. Indeed, this combinatorial approach 
generates a safer gene-therapy platform for clinical and research 
applications than currently used nonintegrating lentiviral vector 
systems, especially in settings requiring large doses of vector par-
ticles in vivo or transient expression of hazardous genes ex vivo.
To date, the relative efficiency of transgene expression from 
the different HIV-1 vector episomes has not been determined. 
Here, we demonstrated that in vitro and in vivo expression from 
PPT-deleted vectors matched the levels of expression from con-
ventional nonintegrating vectors (Figures 4 and 5), indicating 
that the dramatic alteration in the relative amounts of episomal 
HIV-1 vectors induced by the PPT deletion does not affect epi-
somal transgene expression. Taken together, these data suggest 
that transgene expression efficiency from linear episomal HIV-1 
vector genomes (the predominant episomal vector form in cells 
transduced with conventional HIV-1 vectors) is comparable to the 
levels of transgene expression from 1-LTR circles (the predomi-
nant form generated following transduction with PPT-deleted 
vectors).
The development of ZFNs to introduce site-specific DNA 
 double-strand breaks as a means to enhance host DNA repair-
mediated gene editing is considered a major biotechnological 
breakthrough. To avoid genotoxicity associated with continu-
ous expression of ZFNs, Lombardo et al. successfully employed 
nonintegrating HIV-1 vectors to express ZFNs transiently, as well 
as to deliver the donor DNA template required for DNA repair-
mediated gene editing in vitro.33 Although illegitimate integra-





Figure 5 the effect of the polypurine tract (PPt) deletion on trans-
gene expression from lentiviral vectors in vivo. Green fluorescent 
protein expression mediated by PPT+ (vTK945) or PPT− (vTK1023) vec-
tors, packaged into particles containing either functional (IN+) (upper) 
or deficient (IN−) (lower) integrase, in the striatum of the rat brain, was 
measured 2 months after vector infusion. The indicated scale bar is equal 
to 20 µm.
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the donor DNA has not been detected by Lombardo et al., recent 
studies by Cornu et al. indicated that >0.35% of the nonintegrat-
ing HIV-1 vector genomes are expected to illegitimately integrate 
into the host cell genomes.9 Furthermore, the fact that the incor-
poration of donor DNA into double-stranded DNA breaks can be 
mediated by either HR or nonhomologous end-joining suggests 
that the nature of the template DNA could affect the gene editing 
process. In this regard, ZFNs and donor DNA template delivery by 
PPT-deleted vectors could reduce the risks associated with illegiti-
mate integration of either the donor DNA template or the ZFN-
expression cassettes. Furthermore, the low levels of linear vector 
forms generated by PPT-deleted vectors could reduce the occur-
rence of nonhomologous endjoining-based gene correction.
Overall, we present here the development of novel PPT-
deleted vectors that primarily generate 1-LTR circles. The novel 
vectors exhibit impaired integration in the presence of proficient 
HIV-1 integrase and reduced illegitimate integration when pack-
aged into integrase-deficient particles. These features render the 
PPT-deleted vectors safer and more suitable for gene replacement 
therapy and for research and clinical applications, including ZFN-
based gene editing.
MAterIAls And MetHods
Lentiviral vector construction. vTK945 and vTK1054 were described previ-
ously.5 vTK1023 was generated by deleting an NheI fragment from vTK945, 
eliminating the PPT, then inserting an NheI fragment from vTK978. 
vTK1046 was generated by deleting a KpnI/ApaI fragment from vTK459 
and replacing it with a KpnI/ApaI fragment from vTK1023. vTK1179 
was constructed by deleting a PflMI/EcoRV fragment from vTK945 
and replacing it with a PflMI/EcoRV fragment from vTK1074, which 
contains a precise PPT deletion. vTK1074 was generated by perform-
ing two separate PCR experiments with two sets of primers, both using 
vTK459 as template: CCTGGTTGCTGTCTCTTTATGAGG (Fw) and 
GAATTAGCCCTTCCAGTAAAAAGTGGCTAAG (Rev), and CTTAGC 
CACTTTTTACTGGAAGGGCTAATTC (Fw) and CAATGTCAACGCG 
TATATCTGGCCCG (Rev). The resulting amplicons served as templates 
in a second PCR experiment, in which CCTGGTTGCTGTCTCTTTATG 
AGG (Fw) and CAATGTCAACGCGTATATCTGGCCCG (Rev) were 
the primers. The resulting single amplicon was cloned into vTK459 with 
SacII/ApaI to create vTK1074. vTK1187 was created by cloning vTK529, a 
BSD-GFP-containing vector, into vTK945 with AfeI/XhoI, while vTK1188 
was made by cloning vTK529 into vTK1179 with AfeI/XhoI. vTK993 was 
described previously,5 and vTK1034 was generated by cloning vTK1023 
into vTK464, a luciferase-containing vector, with KpnI/PmeI. The term 
vTK refers to a particular DNA construct and the corresponding lentiviral 
vector.
Viral vector production. All lentiviral vectors were prepared as previ-
ously described,34 transiently transfecting 107 293T cells with 15 μg 
vector cassette, 10 μg packaging cassette, and 5 μg envelope cassette. 
Integrating vectors were made using the packaging cassette ΔNRF,34 
which expresses functional integrase, while nonintegrating vectors were 
made using the packaging cassette vTK939, which was made by inserting 
the D64E-mutant integrase from pD64E into ΔNRF by standard cloning 
procedures. All vectors were pseudotyped with the vesicular stomatitis 
virus-glycoprotein envelope cassette. For vectors constitutively expressing 
GFP, titers were assessed by serial dilution in 293T cells followed by visual 
analysis and counting of GFP-positive cells by fluorescence microscope. 
For other vectors, concentrations were determined by p24 gag enzyme-
linked immuno sorbent assay. The absence of replication-competent retro-
viruses was determined by three independent methods: tat transfer assay, 
vector rescue assay, and p24 gag enzyme-linked immunosorbent assay, as 
described previously.35
Cell culture. The following cell lines were used: 293T, AA8, E1KO7-5, 
and ATStg (kind gift from Rodney Nairn, University of Texas), SUM149 
and ME16C2 (kind gift from William Kaufmann, University of North 
Carolina). AA8, E1KO7-5, and ATStg cells were grown in α-MEM 
(Invitrogen, Carlsbad, CA), supplemented with 10% fetal bovine serum. 
SUM149 were grown in HuMEC basal serum free medium (Invitrogen), 
supplemented with 5% fetal bovine serum, HuMEC supplement, and 
25 mg bovine pituitary extract. ME16C2 cells were grown in HuMEC basal 
serum free medium (Invitrogen), supplemented with HuMEC supplement, 
and 25 mg bovine pituitary extract. All media were supplemented with 1% 
penicillin/streptomycin solution.
In vivo experiments in mouse liver. BALB/c mice (Jackson Laboratory, 
Bar Harbor, ME) were injected intraperitoneally at 8 weeks of age with 
40 μg p24 of lentiviral vector. At 21 days postinjection, livers were har-
vested, strained into single-cell suspensions, and subjected to shuttle– 
vector analysis of episome formation.5
FACScan analysis. 293T cells were transduced and analyzed as previously 
described.5 Cell-cycle arrest was achieved by growing AA8 cells to conflu-
ence for 4 days in media containing 1% dimethyl sulfoxide. For cell-cycle 
analysis, cells were harvested, fixed in 70% ethanol (Pharmco-AAPER, 
Brookfield, CT), and incubated in a solution containing 50 μg/ml pro-
pidium iodide (Molecular Probes, Eugene, OR), 100 units/ml RNase A 
(Sigma, St. Louis, MO), 100 mg bovine serum albumin fraction V (Roche, 
Mannheim, Germany), and 10 ml phosphate buffered saline.
Shuttle–vector assay. 293T cells were transduced with integrating or non-
integrating vTK459, vTK1054, or vTK1074 (see above for construction 
details), and mouse livers were transduced with integrating or nonintegrat-
ing vTK1054. Transduced cells were harvested 16 hours post-transduction 
using 0.85 ml Hirt lysis buffer and 0.25 ml 5 mol/l NaCl per 10 cm plate 
of transduced cells, and livers were harvested 21 days post-transduction 
using 14.56 ml sodium dodecyl sulfate-free Hirt lysis buffer, 0.92 ml 10% 
sodium dodecyl sulfate, and 4.36 ml 5 mol/l NaCl per liver. Episomal DNA 
was subsequently subjected to phenol/chloroform extraction and DpnI 
digestion and electroporated into bacteria. Bacterial colonies were cultured 
individually in 2 ml volumes of lysogeny broth medium containing 100 μg/
ml ampicillin and pelleted, and their episomes were extracted by boiling 
in a hotprep buffer made with 5 g sucrose, 4 ml 0.5 mol/l Tris/EDTA solu-
tion, 40 ml 10% Triton X-100 (Sigma), 5 ml 1 mol/l Tris/HCl pH 8.0 and 
water to 100 ml. 700 μl hotprep buffer and 25 μl lysozyme solution (10 mg/
ml lysozyme (Sigma) in 0.25 mol/l Tris/HCl pH 8.0) were added to each 
bacterial pellet, which was resuspended and placed on ice for 5–10 min-
utes before boiling for 1 minute. After boiling, samples were centrifuged 
at 14 K for 10 minutes to dispose of cell debris. The supernatant was then 
mixed with 700 μl isopropanol and centrifuged at 14 K for 10 minutes, then 
the DNA pellet was washed with 70% ethanol, dried, and resuspended in 
50–200 μl water containing 10 μg/ml RNase A. Episomal DNA clones were 
digested with NotI and SacII and electrophoresed in a 1% agarose gel to 
be characterized as 1-LTR, 2-LTR, or mutant circular episomes. For every 
transduction, between 100 and 112 episome-bearing bacterial colonies 
were characterized.
Southern-blot analysis. 293T, E1KO7-5, ATStg, SUM149, ME16C2, and 
AA8 cells were harvested 3 days and p4 after transduction with vTK945 
or vTK1179, and their total DNA was extracted as previously described.36 
10 μg total DNA was digested with DpnI, EcoNI and PflMI and probed 
with either the 1.4 kb KasI/BamHI fragment or the 1.6 kb AfeI/EcoRV frag-
ment of vTK945, except in the case of Supplementary Figure S5, in which 
10 μg total DNA was digested with DpnI (to eliminate plasmid DNA), SphI 
(to cut cellular genomic DNA), and NheI (to cut cellular genomic DNA) 
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or XbaI (to singly cut vector DNA). Samples were probed with the 1.3 kb 
BssHII/XmaI fragment of vTK459. Quantitative analysis of DNA density 
in the Southern blot presented in Figure 3d was achieved using ImageJ 
software.
Quantitative PCR analysis. In this study, vector titers were quantified 
through direct counting of GFP-positive cells and/or p24gag enzyme-linked 
immunosorbent assay of vector stocks, and equal amounts of the lentiviral 
vectors were used for transduction of 293T cells. 293T cells were transduced 
at an multiplicity of infection of 0.5 with PPT+ and PPT-deleted vectors 
expressing GFP or luciferase. After 48 hours or p4 post- transduction cells 
were harvested, and, subsequently, total genomic DNA was extracted and 
treated with DpnI (New England Biolabs, Ipswich, MA). Normalization of 
amounts of genomic DNA was achieved by PCR amplification of the human 
β-globin gene, as previously described.36 β-Globin was targeted with the 
following primers: 5′-CAGAGCCATCTATTGCTTAC-3′(forward) and 
5′-GCCTCACCACCAACTTCATC-3′(reverse). The WPRE was analyzed 
with the following primers: 5′-ACGTCCTTCTGCTACGTCC-3′ (for-
ward), 5′-AAAGGGAGATCCGACCGACTCGTC-3′ (reverse). Flp9 cells 
(293T cells containing one copy of the lentiviral vector vTK113 per diploid 
genome, as previously explained36) were used to establish a standard curve. 
A range of 3.03 × 104 to 15 β-globin cell-equivalent of the Flp9 cells (two 
copies per diploid cell) was used in duplicate to establish the standard curve 
for the β-globin region amplification. A range of 1.5 × 104 to 7.5 of the Flp9 
cells (one copy of the viral DNA per diploid genome) was used in dupli-
cate to establish the standard curve for the viral sequence’s amplification. 
Reactions were labeled with SYBR Green I (Cambrex, East Rutherford, NJ) 
and performed in triplicate on a 7300 Real-Time PCR System (Applied 
Biosystems). Reactions were analyzed using the 7300 Real-Time PCR 
System RQ Study Software Version 1.4 (Applied Biosystems, Foster City, 
CA). 10 μl of each PCR sample was subjected to gel electrophoresis and 
visualized by staining with ethidium bromide.
Quantification of integration by qPCR. 293T cells were transduced at an 
multiplicity of infection of 0.5 with PPT+ and PPT-deleted vectors express-
ing GFP or luciferase. After 48 hours or p4 post-transduction (four 1:5 
 passages being the minimal number required to dilute out unintegrated 
vector genomes, as previously shown36), cells were harvested and genomic 
DNA was isolated by the phenol/chloroform extraction method. Samples 
were analyzed by qPCR, as outlined above, and each vector’s efficiency of 
integration was calculated as a percentage by comparing vector copy num-
ber after p4 with vector copy number after 48 hours.
In vivo experiments in rat brain. All animals were pathogen-free male 
Sprague–Dawley rats obtained from Charles Rivers. All procedures were 
in accordance with the Guide for the Care and Use of Laboratory Animals 
(DHHS Publication No. (National Institutes of Health)85–23), and all 
procedures received prior approval by the University of North Carolina 
Institutional Animal Care and Usage Committee. Virus vector infusions 
were performed as previously described.37 Briefly, rats (N = 4/group) first 
were anesthetized with 50 mg/kg pentobarbital and then placed into a 
 stereotaxic frame. Using a 32 gauge stainless steel injector and a Sage infu-
sion pump, the rats received 1 µl (at 1 × 109 GFP transducing units/ml) of 
the integrating and nonintegrating vTK945 and vTK1023 vectors over a 
10-minute period into the striatum (1.0 mm anterior to bregma, 3.0 mm 
lateral, 5.5 mm vertical) according to the atlas of Paxinos and Watson.38 
In all cases, the injector was left in place 3-minutes postinfusion to allow 
diffusion from the injector.
GFP visualization. Two months after the vector infusion, rats received an 
overdose of pentobarbital (100 mg/kg pentobarbital, i.p.) and subsequently 
were perfused transcardially with ice-cold 100 mmol/l sodium phosphate 
buffered saline (pH = 7.4), followed by 4% paraformaldehyde in 100 mmol/l 
phosphate buffer (pH = 7.4). After overnight fixation in paraformaldehyde-
phosphate buffer, vibratome sections (40 µm thick) were taken through 
the striatum and rinsed in phosphate buffered saline. Following three 
rinses in phosphate buffered saline, the sections were mounted on slides 
and  coverslipped with fluorescent mounting media. eGFP fluorescence 
was visualized on an Olympus IX 71 fluorescence microscope (Olympus, 
Center Valley, PA), and digital pictures were taken. For details on luciferase 
assay see Supplementary Materials and Methods.
suPPleMentArY MAterIAl
Figure S1. Diagram of the vectors used in the study.
Figure S2. PI FACS figure verifying cell-cycle arrest.
Figure S3. Sequence comparison of deleted U3 and PPT sequences 
in vectors.
Figure S4. Diagram of failed strand displacement caused by the PPT 
deletion.
Figure S5. Southern-blot analysis of the effect of the PPT deletion on 
episome formation, performed on undigested DNA from transduced 
cells.
Figure S6. Sequence analysis of deletions and an insertion at the 
2-LTR junction of 2-LTR circles produced by PPT-deleted vectors.
Figure S7. Southern-blot analysis of the effect of the cPPT deletion on 
integration and episomal formation.
Figure S8. Comparison of the reductions in illegitimate integration 
achieved by two PPT-deleted vectors.
Table S1. Quantification of the effect of the PPT deletion on integra-
tion and episomal formation.
Table S2. Titering of vectors packaged with and without functional 
integrase, with and without the PPT.
Materials and Methods.
AcKnoWledGMents
B.K., M.B., and T.K. designed the research, M.B., B.K., T.M., H.M., 
C.L., and R.J.S. carried out experiments and analyzed results, and 
B.K., M.B., and T.K. wrote the manuscript. M.B. and B.K. contributed 
equally to this study. The following reagents were obtained through 
the National Institutes of Health (NIH) AIDS Research and Reference 
Reagent Program, Division of AIDS, NIAID, NIH: pD64E from Dr Vinay 
K. Pathak and HIV-1 p24 monoclonal antibody (183-H12-5C) from Dr 
Bruce Chesebro and Kathy Wehrly. We are grateful to the White Rose, 
Dr McKeon, Aristides de Sousa Mendes, and the efforts on Musa Dagh. 
We would like to thank Nikunj Somia for useful discussions. The study 
was supported by the UNC Center for AIDS Research (CFAR) and by 
NIH grants 2-R01-DK058702-06 to B.K. and T.K., 5-R21-HL086406 to 
R.J.S. and T.K., and 5-PO1-HL066973-05 to T.K. The authors have no 
competing interests to disclose.
reFerences
1. Zaiss, AK, Son, S and Chang, LJ (2002). RNA 3’ readthrough of oncoretrovirus and 
lentivirus: implications for vector safety and efficacy. J Virol 76: 7209–7219.
2. Hacein-Bey-Abina, S, Von Kalle, C, Schmidt, M, McCormack, MP, Wulffraat, N, 
Leboulch, P et al. (2003). LMO2-associated clonal T cell proliferation in two patients 
after gene therapy for SCID-X1. Science 302: 415–419.
3. Leavitt, AD, Shiue, L and Varmus, HE (1993). Site-directed mutagenesis of HIV-1 
integrase demonstrates differential effects on integrase functions in vitro. J Biol Chem 
268: 2113–2119.
4. Yáñez-Muñoz, RJ, Balaggan, KS, MacNeil, A, Howe, SJ, Schmidt, M, Smith, AJ et al. 
(2006). Effective gene therapy with nonintegrating lentiviral vectors. Nat Med 12: 
348–353.
5. Bayer, M, Kantor, B, Cockrell, A, Ma, H, Zeithaml, B, Li, X et al. (2008). A large U3 
deletion causes increased in vivo expression from a nonintegrating lentiviral vector. 
Mol Ther 16: 1968–1976.
6. Apolonia, L, Waddington, SN, Fernandes, C, Ward, NJ, Bouma, G, Blundell, MP 
et al. (2007). Stable gene transfer to muscle using non-integrating lentiviral vectors. 
Mol Ther 15: 1947–1954.
7. Philippe, S, Sarkis, C, Barkats, M, Mammeri, H, Ladroue, C, Petit, C et al. (2006). 
Lentiviral vectors with a defective integrase allow efficient and sustained transgene 
expression in vitro and in vivo. Proc Natl Acad Sci USA 103: 17684–17689.
8. Hu, B, Yang, H, Dai, B, Tai, A and Wang, P (2009). Nonintegrating lentiviral vectors 
can effectively deliver ovalbumin antigen for induction of antitumor immunity. Hum 
Gene Ther 20: 1652–1664.
9. Cornu, TI and Cathomen, T (2007). Targeted genome modifications using integrase-
deficient lentiviral vectors. Mol Ther 15: 2107–2113.
10. Leavitt, AD, Robles, G, Alesandro, N and Varmus, HE (1996). Human 
immunodeficiency virus type 1 integrase mutants retain in vitro integrase activity 
yet fail to integrate viral DNA efficiently during infection. J Virol 70: 721–728.
556 www.moleculartherapy.org  vol. 19 no. 3 mar. 2011 
© The American Society of Gene & Cell Therapy
A Novel Approach for Inhibiting Integration
11. Nakajima, N, Lu, R and Engelman, A (2001). Human immunodeficiency virus type 1 
replication in the absence of integrase-mediated dna recombination: definition of 
permissive and nonpermissive T-cell lines. J Virol 75: 7944–7955.
12. Coffin, JM, Hughes, SM and Varmus, HE (1997). Retroviruses. Cold Spring Harbor 
Laboratory Press: Plainview, New York.
13. Li, L, Olvera, JM, Yoder, KE, Mitchell, RS, Butler, SL, Lieber, M et al. (2001). Role of the 
non-homologous DNA end joining pathway in the early steps of retroviral infection. 
EMBO J 20: 3272–3281.
14. Shoemaker, C, Goff, S, Gilboa, E, Paskind, M, Mitra, SW and Baltimore, D (1980). 
Structure of a cloned circular Moloney murine leukemia virus DNA molecule 
containing an inverted segment: implications for retrovirus integration. Proc Natl Acad 
Sci USA 77: 3932–3936.
15. Farnet, CM and Haseltine, WA (1991). Circularization of human immunodeficiency 
virus type 1 DNA in vitro. J Virol 65: 6942–6952.
16. Dina, D and Benz, EW Jr (1980). Structure of murine sarcoma virus DNA replicative 
intermediates synthesized in vitro. J Virol 33: 377–389.
17. Ringold, GM, Yamamoto, KR, Shank, PR and Varmus, HE (1977). Mouse mammary 
tumor virus DNA in infected rat cells: characterization of unintegrated forms. Cell 10: 
19–26.
18. Folger, KR, Wong, EA, Wahl, G and Capecchi, MR (1982). Patterns of integration 
of DNA microinjected into cultured mammalian cells: evidence for homologous 
recombination between injected plasmid DNA molecules. Mol Cell Biol 2:  
1372–1387.
19. Flint, SJ; American Society for Microbiology. (2009). Principles of Virology. ASM Press: 
Washington, DC.
20. Klarmann, GJ, Yu, H, Chen, X, Dougherty, JP and Preston, BD (1997). Discontinuous 
plus-strand DNA synthesis in human immunodeficiency virus type 1-infected cells and 
in a partially reconstituted cell-free system. J Virol 71: 9259–9269.
21. Elstrodt, F, Hollestelle, A, Nagel, JH, Gorin, M, Wasielewski, M, van den Ouweland, A 
et al. (2006). BRCA1 mutation analysis of 41 human breast cancer cell lines reveals 
three new deleterious mutants. Cancer Res 66: 41–45.
22. Adair, GM, Rolig, RL, Moore-Faver, D, Zabelshansky, M, Wilson, JH and Nairn, RS 
(2000). Role of ERCC1 in removal of long non-homologous tails during targeted 
homologous recombination. EMBO J 19: 5552–5561.
23. Jazayeri, A, Falck, J, Lukas, C, Bartek, J, Smith, GC, Lukas, J et al. (2006). ATM- and cell 
cycle-dependent regulation of ATR in response to DNA double-strand breaks. Nat Cell 
Biol 8: 37–45.
24. Al-Minawi, AZ, Saleh-Gohari, N and Helleday, T (2008). The ERCC1/XPF endonuclease 
is required for efficient single-strand annealing and gene conversion in mammalian 
cells. Nucleic Acids Res 36: 1–9.
25. Ma, H and Kafri, T (2004). A single-LTR HIV-1 vector optimized for functional 
genomics applications. Mol Ther 10: 139–149.
26. Butler, SL, Hansen, MS and Bushman, FD (2001). A quantitative assay for HIV DNA 
integration in vivo. Nat Med 7: 631–634.
27. Nightingale, SJ, Hollis, RP, Pepper, KA, Petersen, D, Yu, XJ, Yang, C et al. (2006). 
Transient gene expression by nonintegrating lentiviral vectors. Mol Ther 13: 1121–1132.
28. Mali, P, Ye, Z, Hommond, HH, Yu, X, Lin, J, Chen, G et al. (2008). Improved efficiency 
and pace of generating induced pluripotent stem cells from human adult and fetal 
fibroblasts. Stem Cells 26: 1998–2005.
29. Gilboa, E, Mitra, SW, Goff, S and Baltimore, D (1979). A detailed model of reverse 
transcription and tests of crucial aspects. Cell 18: 93–100.
30. Hungnes, O, Tjotta, E and Grinde, B (1991). The plus strand is discontinuous in a 
subpopulation of unintegrated HIV-1 DNA. Arch Virol 116: 133–141.
31. Miles, LR, Agresta, BE, Khan, MB, Tang, S, Levin, JG and Powell, MD (2005). Effect 
of polypurine tract (PPT) mutations on human immunodeficiency virus type 1 
replication: a virus with a completely randomized PPT retains low infectivity. J Virol 79: 
6859–6867.
32. Miller, MD, Wang, B and Bushman, FD (1995). Human immunodeficiency virus type 
1 preintegration complexes containing discontinuous plus strands are competent to 
integrate in vitro. J Virol 69: 3938–3944.
33. Lombardo, A, Genovese, P, Beausejour, CM, Colleoni, S, Lee, YL, Kim, KA et al. (2007). 
Gene editing in human stem cells using zinc finger nucleases and integrase-defective 
lentiviral vector delivery. Nat Biotechnol 25: 1298–1306.
34. Xu, K, Ma, H, McCown, TJ, Verma, IM and Kafri, T (2001). Generation of a stable cell 
line producing high-titer self-inactivating lentiviral vectors. Mol Ther 3: 97–104.
35. Kafri, T, van Praag, H, Gage, FH and Verma, IM (2000). Lentiviral vectors: regulated 
gene expression. Mol Ther 1: 516–521.
36. Kantor, B, Ma, H, Webster-Cyriaque, J, Monahan, PE and Kafri, T (2009). Epigenetic 
activation of unintegrated HIV-1 genomes by gut-associated short chain fatty acids 
and its implications for HIV infection. Proc Natl Acad Sci USA 106: 18786–18791.
37. McCown, TJ (2006). Adeno-associated virus-mediated expression and constitutive 
secretion of galanin suppresses limbic seizure activity in vivo. Mol Ther 14: 63–68.
38. Paxinos, G and Watson, C. (1986). The Rat Brain in Stereotaxic Coordinates. Academic 
Press: Orlando, FL.
